Fan Yu-Hong, Zhang Siyao, Wang Ye, Wang Hongni, Li Hongliang, Bai Lan
State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute, Gannan Medical University, Ganzhou, China.
State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute, Ganzhou, China.
Front Endocrinol (Lausanne). 2025 Jan 9;15:1494560. doi: 10.3389/fendo.2024.1494560. eCollection 2024.
Non-alcoholic fatty liver disease (NAFLD) is a multisystem metabolic disorder, marked by abnormal lipid accumulation and intricate inter-organ interactions, which contribute to systemic metabolic imbalances. NAFLD may progress through several stages, including simple steatosis (NAFL), non-alcoholic steatohepatitis (NASH), cirrhosis, and potentially liver cancer. This disease is closely associated with metabolic disorders driven by overnutrition, with key pathological processes including lipid dysregulation, impaired lipid autophagy, mitochondrial dysfunction, endoplasmic reticulum (ER) stress, and local inflammation. While hepatic lipid metabolism in NAFLD is well-documented, further research into inter-organ communication mechanisms is crucial for a deeper understanding of NAFLD progression. This review delves into intrahepatic networks and tissue-specific signaling mediators involved in NAFLD pathogenesis, emphasizing their impact on distal organs.
非酒精性脂肪性肝病(NAFLD)是一种多系统代谢紊乱疾病,其特征是脂质异常蓄积以及复杂的器官间相互作用,这些因素导致全身代谢失衡。NAFLD可能会经历几个阶段,包括单纯性脂肪肝(NAFL)、非酒精性脂肪性肝炎(NASH)、肝硬化以及潜在的肝癌。这种疾病与营养过剩驱动的代谢紊乱密切相关,关键病理过程包括脂质调节异常、脂质自噬受损、线粒体功能障碍、内质网(ER)应激和局部炎症。虽然NAFLD中的肝脏脂质代谢已有充分记录,但进一步研究器官间通讯机制对于深入了解NAFLD进展至关重要。本综述深入探讨了参与NAFLD发病机制的肝内网络和组织特异性信号介质,强调了它们对远端器官的影响。